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Introduction {#phy213954-sec-0001}
============

Epidemiological and experimental studies have recognized that IUGR or the failure of an infant to achieve their genetic potential for growth are prone to developing diseases in later life, including cardiovascular diseases such as hypertension and coronary heart disease (Barker [1994](#phy213954-bib-0007){ref-type="ref"}; Gluckman and Hanson [2004](#phy213954-bib-0023){ref-type="ref"}; McMillen and Robinson [2005](#phy213954-bib-0052){ref-type="ref"}). IUGR is a manifestation of several maternal, paternal and fetal factors, arising from genetic or environmental issues, resulting in poor growth of the developing fetus (Peleg et al. [1998](#phy213954-bib-0066){ref-type="ref"}).

A common cause of IUGR in Western society is uteroplacental insufficiency, occurring when remodeling of placental spiral arteries is incomplete thus, reducing both nutrient and oxygen availability to the developing fetus (Khong et al. [1986](#phy213954-bib-0040){ref-type="ref"}; Henriksen and Clausen [2002](#phy213954-bib-0033){ref-type="ref"}). A bilateral uterine vessel ligation surgery restriction (SR) is often used to mimic this condition in animal studies (Wlodek et al. [2005](#phy213954-bib-0085){ref-type="ref"}). In the developing world, maternal malnutrition is the major cause of IUGR, resulting from lasting nutrient deficiency of the pregnant mother negatively affecting the growing fetus (Bergmann et al. [2008](#phy213954-bib-0010){ref-type="ref"}). Maternal dietary manipulations, such as a food restriction (FR) diet, are used to imitate this condition in animal studies (Williams et al. [2005a](#phy213954-bib-0081){ref-type="ref"},[b](#phy213954-bib-0082){ref-type="ref"}). Several studies utilizing these IUGR animal models have reported changes to vascular smooth muscle responsiveness (Williams et al. [2005a](#phy213954-bib-0081){ref-type="ref"}; Tare et al. [2012](#phy213954-bib-0078){ref-type="ref"}), endothelial dysfunction (Goodfellow et al. [1998](#phy213954-bib-0028){ref-type="ref"}; Leeson et al. [2001](#phy213954-bib-0047){ref-type="ref"}) and increased arterial wall stiffness (Khorram et al. [2007](#phy213954-bib-0041){ref-type="ref"}), which contribute to the development of cardiovascular disease in adulthood.

Evidence of an altered extracellular vascular responsiveness to certain vasoactive chemicals has been widely recognized in several IUGR rat models (Williams et al. [2005a](#phy213954-bib-0081){ref-type="ref"}; Anderson et al. [2006](#phy213954-bib-0005){ref-type="ref"}; Tare et al. [2012](#phy213954-bib-0078){ref-type="ref"} to name a few). However, it is unclear whether these observed changes in vascular sensitivity are driven by changes in receptor number/activity or by changes in downstream events that lead to force development; specifically, the Ca^2+^‐regulated activation of the contractile apparatus. Vascular smooth muscle contraction is primarily controlled by the level of intracellular \[Ca^2+^\] which regulates the balance of myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) activities, biochemically controlling the Ca^2+^--tension relationship through increasing or decreasing phosphorylation of the myosin light chain (MLC) (Kitazawa and Somlyo [1990](#phy213954-bib-0042){ref-type="ref"}; Kitazawa et al. [1991](#phy213954-bib-0043){ref-type="ref"}; Somlyo and Somlyo [2003](#phy213954-bib-0075){ref-type="ref"}). Reducing MLCP activity while increasing MLCK activity through a rise in \[Ca^2+^\]~*i*~ tilts the balance toward generating extra force.

Vascular smooth muscle cells (VSMC) are not terminally differentiated (Owens [1995](#phy213954-bib-0063){ref-type="ref"}), they retain enormous plasticity to fulfil several functions, switching between a contractile and proliferating/synthetic phenotype (Owens et al. [2004](#phy213954-bib-0064){ref-type="ref"}; Salmon et al. [2012](#phy213954-bib-0069){ref-type="ref"}). A contractile phenotype is characterized by an upregulation of smooth muscle markers (Owens [1995](#phy213954-bib-0063){ref-type="ref"}; Hungerford and Little [1999](#phy213954-bib-0036){ref-type="ref"}) which include contractile and cytoskeletal proteins (e.g., *α*‐actin and smooth muscle myosin heavy chain (Myh11)), allowing for the regulation of vascular tone. However, the proliferating/synthetic phenotype downregulates many of those contractile proteins, and synthesis' more structural and extracellular matrix proteins including tropomyosin 4 (TPM4), *β*‐actin, collagen type I and III, which helps repair injured vessels and allows for vascular adaptation in diseased states (Jain [2003](#phy213954-bib-0037){ref-type="ref"}; Yoshida et al. [2008](#phy213954-bib-0091){ref-type="ref"}). The exact mechanisms for activating phenotypic switching is complex and highly variable in different diseased states and often involves Ca^2+^ signaling pathways (House et al. [2008](#phy213954-bib-0034){ref-type="ref"}). In models of IUGR, little is known about the expression of these key protein markers associated with phenotypic switching.

Therefore, the aim of this study is to examine the effects of IUGR on Ca^2+^‐activated force responses in chemically permeabilized artery segments and to further investigate a potential shift in abundance of important protein markers associated with phenotypic switching in adult (6‐month‐old) male and female WKY rat mesenteric arteries. Furthermore, because a systematic examination of the effects of different models of IUGR are not typically made, in this study, we used two different growth restriction models (FR and SR) to compare the effects of a diverse approach to inducing IUGR on vascular smooth muscle responsiveness.

Materials and Methods {#phy213954-sec-0002}
=====================

Ethical approval {#phy213954-sec-0003}
----------------

All experimental procedures were approved by the La Trobe University Animal Ethics Committee (AEC no. 14‐22) and conform to the National Health and Medical Research Council of Australia guidelines.

Animal models {#phy213954-sec-0004}
-------------

WKY rat dams were housed at 22°C on a 12:12 h light/dark cycle with ad libitum access to standard rat chow and water. Dams were mated overnight after they were identified to be in proestrus (Wlodek et al. [2003](#phy213954-bib-0084){ref-type="ref"}, [2005](#phy213954-bib-0085){ref-type="ref"}; O\'Dowd et al. [2008](#phy213954-bib-0059){ref-type="ref"}). Pregnancy was confirmed by sperm present in the vaginal smear obtained the following morning; this was considered day 1 of gestation. Pregnant dams were then randomly designated to either a FR diet or uteroplacental insufficiency protocol to induce IUGR.

Rats designated to the FR protocol were housed individually with food intake measured daily throughout pregnancy. On gestational day 15, 11 dams were randomly selected to undergo a 60% FR diet (based on each dam\'s average daily food intake prior to day 15; *N* = 11); as previously described by (Williams et al. [2005a](#phy213954-bib-0081){ref-type="ref"},[b](#phy213954-bib-0082){ref-type="ref"}; Harvey et al. [2015](#phy213954-bib-0030){ref-type="ref"}). The nine remaining dams (untreated C; *N* = 9) had continuous ad libitum access to food. Following birth (term = day 22), all dams were given ad libitum access to food.

Pregnant rats designated to the uteroplacental insufficiency model were housed together until gestation day 18 before being randomly divided into a SC (sham surgery; *N* = 12) or SR (uteroplacental insufficiency; *N* = 10) group, before undergoing a bilateral uterine vessel ligation surgery, as previously described (Wlodek et al. [2005](#phy213954-bib-0085){ref-type="ref"}, [2007](#phy213954-bib-0086){ref-type="ref"}; O\'Dowd et al. [2008](#phy213954-bib-0059){ref-type="ref"}). Litter size was not equalized between groups, as it has been demonstrated that reducing litter size can impair maternal lactation and postnatal growth, and thus do not represent adequate controls (O\'Dowd et al. [2008](#phy213954-bib-0059){ref-type="ref"}; Wadley et al. [2008](#phy213954-bib-0079){ref-type="ref"}; Wlodek et al. [2008](#phy213954-bib-0087){ref-type="ref"}).

Mesenteric artery isolation and assessment of functionality {#phy213954-sec-0005}
-----------------------------------------------------------

Offspring were weighed on postnatal day 1 and weaned at 5‐weeks of age with sexes separately housed. From each litter, a single male and female offspring was used for both physiological and biochemical experiments at 6‐months of age; which represents an adult human (\~35--40 years old). On the experimental day, offspring were killed by overdose of isoflurane (4% v/v) inhalation in a glass chamber, with the heart being rapidly excised to ensure death. A large portion of the intestine, cut at the proximal end near the pylorus and distal end close to the ileo--coecal junction, was excised and pinned out onto a Sylgard coated petri dish placed in cold standard physiological saline solution (PSS; containing in mM: 10 HEPES, 150 NaCl, 3 KCl, 2.5 CaCl~2~, 1 MgCl~2~ and 5.5 glucose; pH 7.3), with constant 100% O~2~ aeration whilst the mesenteric artery was isolated. All chemicals were sourced from Sigma‐Aldrich (St Louis, USA) unless otherwise specified.

A small \~2 mm long section of 3rd order mesenteric artery was separated from the vein and placed in the single wire myograph system (320A, Danish Myo Technology A/S, Denmark) containing warmed (37°C) PSS. Two 40 *μ*m diameter wires were threaded through the lumen of each artery, with length of each preparation being carefully measured (Mulvany and Halpern [1977](#phy213954-bib-0055){ref-type="ref"}). Each artery underwent an equilibration period (30 min) before being normalized, as previously described (Mulvany and Halpern [1977](#phy213954-bib-0055){ref-type="ref"}; Anderson et al. [2006](#phy213954-bib-0005){ref-type="ref"}). The arterial preparation was equilibrated for an additional 30 min, followed by a standard start procedure, as previously described (McIntyre et al. [1998](#phy213954-bib-0051){ref-type="ref"}; Anderson et al. [2006](#phy213954-bib-0005){ref-type="ref"}), before the functionality of each mesenteric artery was investigated; note, endothelium integrity was checked through responsiveness to 10^−6^ mol/L acetylcholine. Briefly, the intact preparation was exposed to K^+^‐PSS (equimolar substitution of NaCl with KCl in PSS) which initiated a K^+^‐induced depolarization contractile response. The vessel was also exposed to increasing concentrations of PE (10^−8^--10^−4^ mol/L) to determine the *α* ~1A~‐adrenergic receptor‐mediated contractile responsiveness. Maximum responsiveness to K^+^‐PSS and PE was measured by normalizing peak force (mN) to the arteries length (mm).

Determining Ca^2+^‐sensitivity and maximum Ca^2+^‐activated force response {#phy213954-sec-0006}
--------------------------------------------------------------------------

To ascertain the properties of the contractile apparatus specifically, the same artery preparation was then chemically permeabilized with 50 *μ*mol/L *β*‐escin in a heavily Ca^2+^‐buffered K^+^‐EGTA solution (solution A; containing in mmol/L: 50 EGTA, 90 HEPES, 10.3 Mg^2+^ ~total~, (1 free Mg^2+^), 8 ATP ~total~, 10 creatine phosphate, 125 K^+^, 36 Na^+^; pH 7.10 ± 0.01) for 30 min at room temperature (22°C), as previously described by Satoh et al. ([1994](#phy213954-bib-0072){ref-type="ref"}). Note: we have conducted numerous control experiments to ascertain the optimal permeabilization conditions for this preparation (Christie [2018](#phy213954-bib-0017){ref-type="ref"}). Each artery was washed with solution A three times before a Ca^2+^‐response curve was performed, by exposure to a sequence of highly buffered Ca^2+^‐EGTA solutions with increasing levels of free \[Ca^2+^\] (pCa (−log \[Ca^2+^\]) 7.5--4.5), by mixing suitable volumes of solution A with a Ca^2+^‐EGTA solution (solution B: pCa 4.5) which was identical in composition to solution A with the exception that it contained in mmol/L: 8.12 Mg^2+^ ~total~ (1 free Mg^2+^), 49.7 Ca^2+^ ~total~ (see Stephenson and Williams ([1981](#phy213954-bib-0077){ref-type="ref"}) for apparent affinity constants). As the level of free \[Ca^2+^\] increased there was a step‐wise increase in force which was used to create a force--pCa relationship for each chemically permeabilized arterial preparation. All intracellular physiological solutions contained 50 units per ml of creatine phosphokinase and 10 *μ*mol/L guanosine‐5′‐triphosphate as this has been previously shown to help maintain consistent force production throughout experiments (Akata and Boyle [1997](#phy213954-bib-0003){ref-type="ref"}).

The Ca^2+^‐sensitivity of the contractile apparatus was ascertained by normalizing all submaximal force responses elicited to low pCa solution, to the maximum Ca^2+^‐activated force, which was plotted against the pCa. A nonlinear regression, specifically single exponential association derived from equation 1 was used to fit the points of the curve for each preparation, using GraphPad Prism 6.01 (as described previously by Williams et al. ([2017](#phy213954-bib-0083){ref-type="ref"})).

$$\begin{array}{cl}
Y & {= \text{Bottom} + (\text{Top} - \text{Bottom})/} \\
 & {\quad\left( {1 + 10\left( {\left( \text{LogEC50‐X} \right) \ast \text{Hill\ slope}} \right)} \right),} \\
\end{array}$$

where *Y *= *Y*‐axis; Bottom = smallest *Y* value at the bottom of the plateau (0%); Top = largest *Y* value at the top of the plateau (100%); EC~50~ = *X* value which represents half‐maximal (*Y*) response; *X *= *X*‐axis; Hill slope = gradient of the curve.

The pCa that elicits 50% of the maximum Ca^2+^‐activated force response (pCa~50~) and the Hill slope coefficient was collected from each fitted curve and averaged. These values were then used to create a representative curve. This approach was employed as it is better than plotting the overall mean data for each preparation and then fitting a single curve to the mean data, as the latter has the possibility of artificially skewing the fitted curve providing an incorrect assessment of the individual preparations responsiveness to Ca^2+^ (Lamb and Stephenson [1990](#phy213954-bib-0045){ref-type="ref"}, [1994](#phy213954-bib-0046){ref-type="ref"}; Posterino et al. [2000](#phy213954-bib-0067){ref-type="ref"}). The maximum Ca^2+^‐activated force was measured by normalizing the peak force (mN) to the arteries length (mm).

Western blotting {#phy213954-sec-0007}
----------------

A second \~4 mm long section of 3rd order mesenteric artery was taken from an adjacent arterial arcade to the previous preparation. The preparation was physically homogenized with a glass Dounce tissue grinder (2 mL; Sigma‐Aldrich) whilst frozen with liquid nitrogen, then chemically homogenized with 200 *μ*L of 1 × solubilizing buffer, containing: 0.125 mol/L Tris‐HCl, 10% glycerol, 4% SDS, 4 mol/L urea, 10% mercaptoethanol and \~0.001% bromophenol blue (pH 6.8) diluted (2:1 v/v) in a modified PSS solution (2.5 mmol/L CaCl~2~ removed and 2 mmol/L EGTA added). Preparations were stored at −80°C until analysed by western blotting using a protocol described previously (MacInnis et al. [2017](#phy213954-bib-0048){ref-type="ref"}).

Briefly, homogenized artery samples were loaded onto a 4--15% criterion TGX stain‐free protein gel (Bio‐Rad, Hercules, CA, USA). A 4‐point calibration curve of known volumes (2, 4, 8 and 16 *μ*L) was generated by loading a calibration mix, as previously described (Edwards et al. [2010](#phy213954-bib-0020){ref-type="ref"}; Murphy and Lamb [2013](#phy213954-bib-0056){ref-type="ref"}). Ultraviolet activation of the gel allowed visualization of total protein loaded and was subsequently analyzed using ImageLab 5.2.1 (Bio‐Rad). Separated proteins were transferred to a stable nitrocellulose membrane. Membranes were cut horizontally, and individual sections were probed with specific primary antibodies diluted in 1% BSA in PBS with 0.025% Tween incubated at room temperature for 2 h and 4°C overnight on rockers. The proteins of interest include: *α* ~1C~ L‐type voltage gated Ca^2+^‐channel (Ca~V~1.2; rabbit polyclonal IgG; 1:1000; AB5156; lot no. 2710733; Merck Millipore, Germany), inositol trisphosphate receptor 1 (IP~3~R1; mouse monoclonal IgG; 1:100; L24/18; lot no. 437‐1VA‐71; NeuroMab, USA), MLCK (mouse monoclonal IgG; 1:1000; M7905; Sigma‐Aldrich, USA), myosin phosphatase target subunit 1 (Mypt1; rabbit polyclonal IgG; 1:1000 sc‐25618; lot no. C2415; Santa Cruz, USA), Myh11 (mouse monoclonal IgG; 1:10,000; sc‐6956; lot no. C1815; Santa Cruz, USA), *α*‐actin (rabbit polyclonal IgG; 1:10,000; ab5694; lot no. GR248336‐21; Abcam, UK) and TPM4 (rabbit polyclonal IgG; 1:1000; AB5449; lot no. 2742738; Merck Millipore, Germany); note: all antibodies were independently verified in our laboratory using tissue panels (Christie [2018](#phy213954-bib-0017){ref-type="ref"}).

Membranes were washed and the applicable secondary antibody applied, either goat anti‐rabbit IgG HRP (Pierce 31460; 1:20,000; ThermoFisher Scientific) or goat anti‐mouse IgG HRP secondary antibody (Pierce 31430; 1:20,000; ThermoFisher Scientific) for 1 h at room temperature. Membrane sections were then washed before being exposed to either highly sensitive enhanced chemiluminescent (Pierce) substrate or Supersignal West Femto (Pierce), imaged with ChemiDoc MP (Bio‐Rad) and analyzed, using ImageLab 5.2.1 (Bio‐Rad).

The 4‐point calibration curve was constructed, and the slopes of linear regression used to compare relative amounts of protein between unknown samples, as demonstrated previously (Mollica et al. [2009](#phy213954-bib-0053){ref-type="ref"}; Murphy and Lamb [2013](#phy213954-bib-0056){ref-type="ref"}). Using the calibration curve, the relative amount of total protein in each lane, and subsequent density of each band could be accurately measured by expressing each relative to the calibration curve. The relative amount of each specific protein could then be normalized to the relative total protein. These values were further normalized through dividing by the average of "control" sample densities, which is why "control" values will always equal 1 ± SD, whereas, "restricted" samples will increase/decrease relative to that value.

Statistical analysis {#phy213954-sec-0008}
--------------------

Datasets are expressed as mean ± SD, with number of individuals denoted as *N*. Unpaired student\'s *t*‐tests were used to determine statistical significance (*P *≤* *0.05), unless otherwise specified. All statistical analyses and data fitting was performed using GraphPad Prism 6.01. Note that one‐tailed *t*‐tests were used to analyse data throughout this study, as previous studies have demonstrated a specific shift in contractile force in one direction (Williams et al. [2005a](#phy213954-bib-0081){ref-type="ref"}; Anderson et al. [2006](#phy213954-bib-0005){ref-type="ref"}; Tare et al. [2012](#phy213954-bib-0078){ref-type="ref"}).

Results {#phy213954-sec-0009}
=======

Offspring body weight {#phy213954-sec-0010}
---------------------

There was no difference in litter sizes between the untreated C and FR group (\~10 pups each litter). Uteroplacental insufficiency resulted in a litter size which were approximately 50% smaller in comparison to the SC group (from 7 to 4 pups) at birth. The body weight of pups from each experimental group (males and females combined) on postnatal day 1 was significantly different from all other groups (*P *≤* *0.05; one‐way ANOVA with Tukey correction); SR pups were smallest (3.7 ± 0.6 g), followed by FR pups (4.1 ± 0.3 g), then SC pups (4.4 ± 0.4 g) and lastly untreated C pups were heaviest (4.7 ± 0.3 g). It is interesting to note, as others have found (Nusken et al. [2008](#phy213954-bib-0058){ref-type="ref"}), that even the sham operation (SC group) or the necessary direct exposure to anaesthesia, affects fetal development and resulted in significantly smaller pup sizes in comparison to the untreated C group.

By 6 months of age, all experimental male groups had similar body weights (C: 374 ± 14 g; FR: 369 ± 19 g; SC: 381 ± 16 g; SR: 374 ± 35 g), whereas, SR females remained significantly smaller than C (*P *≤* *0.05; one‐way ANOVA with Tukey correction), but were not statistically different to both FR and SC females (C: 219 ± 5 g; FR: 217 ± 9 g; SC: 214 ± 9 g; SR: 203 ± 20 g).

Intact mesenteric artery reactivity and functionality responses {#phy213954-sec-0011}
---------------------------------------------------------------

Resistance mesenteric arteries underwent a K^+^‐induced depolarization which initiated a contractile response to determine depolarization‐induced peak force (see Table [1](#phy213954-tbl-0001){ref-type="table"}). Both FR and SR male experimental groups had significantly reduced contractile responses compared to their respected control groups (C and SC). Within female experimental groups, peak responsiveness was not different (C vs. FR; SC vs. SR).

###### 

Mesenteric artery responsiveness to a K^+^‐induced depolarization and PE‐stimulation

                               C              FR                                                       SC            SR
  ---------------------------- -------------- -------------------------------------------------------- ------------- --------------------------------------------------------
  Male                         \(9\)          \(8\)                                                    \(8\)         \(8\)
  Peak K^+^‐response (mN/mm)   8.73 ± 1.38    6.95 ± 0.49[\*\*](#phy213954-note-0002){ref-type="fn"}   8.22 ± 1.50   6.14 ± 1.32[\*\*](#phy213954-note-0002){ref-type="fn"}
  Max PE‐response (mN/mm)      10.25 ± 1.39   9.94 ± 1.24                                              9.81 ± 1.46   8.01 ± 0.59[\*\*](#phy213954-note-0002){ref-type="fn"}
  pPE~50~ (−log M)             5.62 ± 0.20    5.69 ± 0.23                                              5.80 ± 0.34   5.60 ± 0.16
  Hill slope                   3.41 ± 0.72    3.56 ± 0.86                                              3.76 ± 1.31   3.63 ± 1.68
  Female                       \(9\)          \(11\)                                                   \(12\)        \(10\)
  Peak K^+^‐response (mN/mm)   6.94 ± 0.69    6.67 ± 1.33                                              6.25 ± 1.34   5.79 ± 1.66
  Max PE‐response (mN/mm)      8.41 ± 1.23    8.85 ± 1.74                                              6.99 ± 1.70   6.89 ± 2.38
  pPE~50~ (−log M)             5.61 ± 0.20    5.68 ± 0.22                                              5.64 ± 0.16   5.63 ± 0.08
  Hill Slope                   3.24 ± 0.92    3.68 ± 0.98                                              3.49 ± 1.69   3.02 ± 0.64

Data expressed as mean ± SD with number of individuals (*N*) shown in brackets. Significant difference (\*\**P* \< 0.01; one‐tailed unpaired *t*‐test) between relevant control and restricted (C vs. FR; SC vs. SR) experimental groups.

John Wiley & Sons, Ltd

Contractile responses to the *α* ~1A~‐adrenergic receptor‐mediated agonist (PE) was measured in each experimental group (Table [1](#phy213954-tbl-0001){ref-type="table"}). Peak response to PE was significantly reduced in SR males compared to the SC experimental group, whereas no differences in peak force were discovered between FR and C males. Furthermore, peak PE‐response was unchanged between female experimental groups. PE‐sensitivity was unaffected by growth restriction in utero in both male and female experimental groups as determined by the pPE~50~ and Hill slope values shown in Table [1](#phy213954-tbl-0001){ref-type="table"}.

Ca^2+^‐activated force responses in *β*‐escin permeabilized mesenteric arteries {#phy213954-sec-0012}
-------------------------------------------------------------------------------

The Ca^2+^‐sensitivity and maximum Ca^2+^‐activated force was measured in each *β*‐escin permeabilized preparation by directly activating the contractile apparatus with an increasing concentration of free \[Ca^2+^\] (pCa 7.5 to pCa 4.5) heavily buffered as displayed in Figure [1](#phy213954-fig-0001){ref-type="fig"}. A representative force--pCa relationship which closely follows the average pCa~50~ and Hill slope value are shown in Figure [1](#phy213954-fig-0001){ref-type="fig"}. Table [2](#phy213954-tbl-0002){ref-type="table"} shows the mean data. There were no apparent differences in Ca^2+^‐sensitivity between growth restriction models for both sexes as indicated by pCa~50~ and Hill slope. However, maximum Ca^2+^‐activated force (normalized to length of preparation) was significantly decreased in both growth restricted male groups (FR and SR) compared to their respective controls (C and SC). This reduced maximum Ca^2+^‐activated force was not observed in either female experimental groups.

![Representative force--pCa relationship. Individually fitted representative curve which closely follows the mean pCa~50~ and Hill Slope shown in Table [4](#phy213954-tbl-0004){ref-type="table"} from (A) male control versus FR and (B) male SC versus SR. (C) Female control versus FR and (D) female SC versus SR. No statistical differences were present between experimental groups.](PHY2-6-e13954-g001){#phy213954-fig-0001}

###### 

Ca^2+^‐sensitivity of the contractile apparatus and maximum Ca^2+^‐activated force in the mesenteric artery

                                C             FR                                                     SC            SR
  ----------------------------- ------------- ------------------------------------------------------ ------------- ------------------------------------------------------
  Male                          \(9\)         \(8\)                                                  \(8\)         \(8\)
  Max Ca^2+^‐response (mN/mm)   3.09 ± 0.41   2.72 ± 0.39[\*](#phy213954-note-0003){ref-type="fn"}   2.91 ± 0.65   2.49 ± 0.24[\*](#phy213954-note-0003){ref-type="fn"}
  pCa~50~ (−log M)              6.08 ± 0.10   6.11 ± 0.17                                            6.16 ± 0.12   6.12 ± 0.15
  Hill slope                    2.39 ± 0.55   2.75 ± 1.34                                            3.23 ± 1.74   2.45 ± 0.73
  Female                        \(8\)         \(11\)                                                 \(12\)        \(10\)
  Max Ca^2+^‐response (mN/mm)   2.76 ± 0.31   2.83 ± 0.58                                            2.49 ± 0.53   2.77 ± 0.75
  pCa~50~ (−log M)              5.97 ± 0.10   6.02 ± 0.10                                            6.12 ± 0.08   6.07 ± 0.05
  Hill slope                    3.25 ± 1.33   3.73 ± 1.56                                            3.30 ± 0.52   3.12 ± 1.26

Data expressed as mean ± SD with number of individuals (*N*) shown in brackets. Significant difference (\**P* ≤ 0.05; one‐tailed unpaired *t*‐test) between relevant control and restricted (C vs. FR; SC vs. SR) experimental groups.

John Wiley & Sons, Ltd

Mesenteric artery contractile protein expression {#phy213954-sec-0013}
------------------------------------------------

Representative western blots investigating important contractile proteins in individual mesenteric artery samples along with respective calibration curve (e.g., 2, 4, 8 16 *μ*L), which consisted of pooled mesenteric artery samples are displayed in Figure [2](#phy213954-fig-0002){ref-type="fig"} (male data) and Figure [3](#phy213954-fig-0003){ref-type="fig"} (female data). Densitometric analysis of blots with mean ± SD values are shown in Table [3](#phy213954-tbl-0003){ref-type="table"} (male data) and Table [4](#phy213954-tbl-0004){ref-type="table"} (female data).

![Representative western blots of the relative abundance of important contractile proteins from mesenteric artery samples of 6‐month‐old male offspring. Relative content (bottom panel) of (A) Ca~V~1.2, (B) IP~3~R1, (C) MLCK, (D) Mypt1, (E) *α*‐actin, (F) Myh11 and (G) TPM4 on western blot with the total protein indicated by the stain free gel (top panel) from control diet (C), food restricted (FR), surgical control (SC) and surgical restricted (SR) male offspring. Calibration curve with amount loaded (in *μ*L) specified at top in all panels. All lanes shown are from same gel. Mean ± SD values and statistical analysis displayed in Table [3](#phy213954-tbl-0003){ref-type="table"}.](PHY2-6-e13954-g002){#phy213954-fig-0002}

![Representative western blots of the relative abundance of important contractile proteins from mesenteric artery samples of 6‐month‐old female offspring. Relative content (bottom panel) of (A) Ca~V~1.2, (B) IP~3~R1, (C) Myh11, (D) *α*‐actin and (E) TPM4 on western blot with the total protein indicated by the stain free gel (top panel) from control diet (C), food restricted (FR), surgical control (SC) and surgical restricted (SR) female offspring. Calibration curves with amount loaded (in *μ*L) specified at top in all panels. All lanes shown are from same gel. Mean ± SD values and statistical analysis displayed in Table [4](#phy213954-tbl-0004){ref-type="table"}.](PHY2-6-e13954-g003){#phy213954-fig-0003}

###### 

Relative abundance of important contractile proteins from mesenteric artery samples of 6‐month‐old male offspring

                   C (9)         FR (8)                                                     SC (8)        SR (8)
  ---------------- ------------- ---------------------------------------------------------- ------------- --------------------------------------------------------
  Ca~V~1.2                                                                                                
  Total density    1.00 ± 0.10   0.48 ± 0.08[\*\*\*](#phy213954-note-0004){ref-type="fn"}   1.00 ± 0.07   0.63 ± 0.12[\*\*](#phy213954-note-0004){ref-type="fn"}
  \~240 kDa band   1.00 ± 0.11   0.29 ± 0.07[\*\*\*](#phy213954-note-0004){ref-type="fn"}   1.00 ± 0.08   0.54 ± 0.12[\*\*](#phy213954-note-0004){ref-type="fn"}
  \~190 kDa band   1.00 ± 0.49   1.08 ± 0.29                                                1.00 ± 0.12   1.42 ± 0.16[\*](#phy213954-note-0005){ref-type="fn"}
  IP~3~R1          1.00 ± 0.07   0.45 ± 0.14[\*\*\*](#phy213954-note-0004){ref-type="fn"}   1.00 ± 0.08   0.54 ± 0.14[\*\*](#phy213954-note-0004){ref-type="fn"}
  MLCK             1.00 ± 0.12   0.48 ± 0.12[\*\*](#phy213954-note-0004){ref-type="fn"}     1.00 ± 0.14   0.46 ± 0.11[\*\*](#phy213954-note-0004){ref-type="fn"}
  Mypt1            1.00 ± 0.11   0.56 ± 0.10[\*\*](#phy213954-note-0004){ref-type="fn"}     1.00 ± 0.11   0.68 ± 0.10[\*\*](#phy213954-note-0004){ref-type="fn"}
  *α*‐actin        1.00 ± 0.49   1.16 ± 0.43                                                1.00 ± 0.16   1.60 ± 0.24[\*](#phy213954-note-0004){ref-type="fn"}
  Myh11            1.00 ± 0.30   0.84 ± 0.41                                                1.00 ± 0.09   0.75 ± 0.11[\*](#phy213954-note-0004){ref-type="fn"}
  TPM4             1.00 ± 0.39   0.89 ± 0.54                                                1.00 ± 0.23   1.14 ± 0.43

Data expressed as mean ± SD with number of individuals (*N*) shown in brackets. Significant difference (\**P* ≤ 0.05; \*\**P *\< 0.01; \*\*\**P *\< 0.001; one‐tailed unpaired *t*‐test) between relevant control and restricted (C vs. FR; SC vs. SR) experimental groups.

John Wiley & Sons, Ltd

###### 

Relative abundance of important contractile proteins from mesenteric artery samples of 6‐month‐old female offspring

                   C (8)         FR (11)                                                SC (12)       SR (10)
  ---------------- ------------- ------------------------------------------------------ ------------- -------------
  Ca~V~1.2                                                                                            
  Total density    1.00 ± 0.10   1.37 ± 0.18[\*](#phy213954-note-0005){ref-type="fn"}   1.00 ± 0.34   0.95 ± 0.42
  \~240 kDa band   1.00 ± 0.37   1.43 ± 0.84                                            1.00 ± 0.36   0.89 ± 0.46
  \~190 kDa band   1.00 ± 0.13   1.48 ± 0.19[\*](#phy213954-note-0005){ref-type="fn"}   1.00 ± 0.43   1.31 ± 0.77
  IP~3~R1          1.00 ± 0.45   0.74 ± 0.46                                            1.00 ± 0.43   0.92 ± 0.44
  *α*‐actin        1.00 ± 0.44   1.11 ± 0.52                                            1.00 ± 0.29   1.05 ± 0.72
  Myh11            1.00 ± 0.75   0.71 ± 0.40                                            1.00 ± 0.39   0.98 ± 0.45
  TPM4             1.00 ± 0.34   0.86 ± 0.37                                            1.00 ± 0.43   1.11 ± 0.51

Data expressed as mean ± SD with number of individuals (*N*) shown in brackets. Significant difference (\**P* ≤ 0.05; one‐tailed unpaired *t*‐test) between relevant control and restricted (C vs. FR; SC vs. SR) experimental groups.

John Wiley & Sons, Ltd

The relative amount of the total L‐type voltage‐gated Ca^2+^ channel (Ca~V~1.2; both bands detected) was decreased in FR males compared to C (*P *\<* *0.001). Analysis of individual bands revealed the FR males to have less of the large subtype (240 kDa top band) relative to the C rats (*P *\<* *0.001), whereas, the abundance of the small subtype (190 kDa bottom band) was not different (*P *\>* *0.05). Relative to C males, FR males had decreased amounts of IP~3~R1 (*P *\<* *0.001), MLCK (*P *\<* *0.01), and Mypt1 (*P *\<* *0.01), whereas Myh11, *α*‐actin and TPM4 content were not different between the FR and C experimental groups.

Comparing SR and SC males, the relative total abundance of Ca~V~1.2 and specifically the large subunit (240 kDa band) was significantly (*P *\< 0.01) decreased, whereas, the relative content of the small subtype (190 kDa bottom band) was significantly increased (*P *≤ 0.05). There were decreases in the relative abundances of IP~3~R1 (*P *\< 0.01), MLCK (*P *\< 0.01), Mypt1 (*P *\< 0.01) and Myh11 (*P *≤ 0.05) was significantly decreased, whereas, *α*‐actin content was increased in SR males compared to SC (*P* ≤ 0.05).

Comparing FR females to controls, the relative total amount of Ca~V~1.2 and specifically the smaller subtype (190 kDa) was increased (*P *≤ 0.05), whereas, the relative abundance of the large subtype (240 kDa top band) of Ca~V~1.2 was unchanged. Likewise, the relative content of IP~3~R1, TPM4, Myh11 and *α*‐actin were not different (all *P* \> 0.05). Furthermore, comparing SC and SR females, the relative abundance of all contractile proteins investigated were unchanged (all *P *\> 0.05).

Discussion {#phy213954-sec-0014}
==========

We have investigated the effects of two different growth restriction models on the resistance mesenteric artery of 6‐month‐old male and female WKY rats. A reduction in maternal nutrient supply from gestational day 15 to term (FR group) resulted in reduced dam growth leading to low birth weight offspring (below 10th percentile), which is consistent with previous studies (Williams et al. [2005a](#phy213954-bib-0081){ref-type="ref"},[b](#phy213954-bib-0082){ref-type="ref"}). The effects of reduced in utero blood perfusion from gestational day 18 to term (SR group), which restricts both oxygen (hypoxic) and nutrient supply, on offspring birth weight was consistent with other reports (Wlodek et al. [2008](#phy213954-bib-0087){ref-type="ref"}; Tare et al. [2012](#phy213954-bib-0078){ref-type="ref"}).

However, 6‐month‐old growth restricted male offspring had a significant reduction in maximum force when stimulated with extracellular agonists (PE and a K^+^‐induced depolarization), whereas females were unaffected. Novel findings from this study demonstrate that changes in responsiveness to extracellular agonists in growth restricted males typically reported in the literature are due to a significant reduction in maximum Ca^2+^‐activated force, with an associated reduced abundance of important contractile proteins and receptors/channels, which was not observed in growth restricted females.

Six‐month‐old male mesenteric artery changes {#phy213954-sec-0015}
--------------------------------------------

Several studies have observed an altered vascular responsiveness leading to vascular dysfunction in adult offspring exposed to maternal perturbations during fetal development (Williams et al. [2005a](#phy213954-bib-0081){ref-type="ref"}; Anderson et al. [2006](#phy213954-bib-0005){ref-type="ref"}; Tare et al. [2012](#phy213954-bib-0078){ref-type="ref"} to name a few). However, the underlying physiological and biochemical changes responsible remain unknown. Our results show that 6‐month‐old male growth restricted offspring (FR and SR) have a significant reduction in maximum Ca^2+^‐activated force (Table [2](#phy213954-tbl-0002){ref-type="table"}), which can help explain the decreased response to a K^+^‐induced depolarization and PE‐stimulation (Table [1](#phy213954-tbl-0001){ref-type="table"}). Activating the voltage‐ or receptor‐operated contractile pathways elevates \[Ca^2+^\]~i~ which subsequently increases the activity of MLCK that phosphorylates MLC leading to vasoconstriction (Barron et al. [1979](#phy213954-bib-0008){ref-type="ref"}; Kamm and Stull [1985](#phy213954-bib-0038){ref-type="ref"}). Our results show that both FR and SR 6‐month‐old males downregulated the expression of MLCK (Fig. [2](#phy213954-fig-0002){ref-type="fig"}C) which may contribute to the decrease in maximum Ca^2+^‐activated force (Basu et al. [2013](#phy213954-bib-0009){ref-type="ref"}). Gao et al. ([2013](#phy213954-bib-0022){ref-type="ref"}) found that a 50% reduction in MLCK abundance in aortic smooth muscle resulted in a 40% inhibition in contractile response. It has also been reported that the mesenteric artery from smooth muscle specific MLCK knockout mice have reduced responsiveness to a K^+^‐induced depolarization and PE‐stimulation, and that these mice have significantly lower resting blood pressures (He et al. [2011](#phy213954-bib-0031){ref-type="ref"}).

Several research groups have hypothesized that the change in responsiveness to PE‐stimulation or other vasoconstrictors in growth restricted animals may be due to a shift in the abundance of key receptors (Williams et al. [2005a](#phy213954-bib-0081){ref-type="ref"}; Anderson et al. [2006](#phy213954-bib-0005){ref-type="ref"}). PE binds to the *α* ~1A~‐adrenergic receptor, which produces the second messenger IP~3~, that activates its receptor (IP~3~R1) located on the internal Ca^2+^ store (sarcoplasmic reticulum) (Seasholtz et al. [1999](#phy213954-bib-0074){ref-type="ref"}; Sah et al. [2000](#phy213954-bib-0068){ref-type="ref"}). Our results show that both male 6‐month‐old growth restricted groups (FR and SR) had a significant reduction in abundance of IP~3~R1 (Fig. [2](#phy213954-fig-0002){ref-type="fig"}B); albeit only SR males had a significant decrease in maximum PE‐induced force response (Table [1](#phy213954-tbl-0001){ref-type="table"}). Tare et al. ([2012](#phy213954-bib-0078){ref-type="ref"}) using the same SR model discovered similar results with male offspring having a significant negative shift in sensitivity to PE. IP~3~R abundance is found to be altered in several diseased states, including hypertension (Adebiyi et al. [2012](#phy213954-bib-0002){ref-type="ref"}; Abou‐Saleh et al. [2013](#phy213954-bib-0001){ref-type="ref"}) and atherosclerosis (Ewart et al. [2010](#phy213954-bib-0021){ref-type="ref"}). Generally, IP~3~R expression is upregulated in hypertensive models, such as genetic hypertension (Adebiyi et al. [2012](#phy213954-bib-0002){ref-type="ref"}) and within the spontaneously hypertensive rat model (Guillemette and Bernier [1993](#phy213954-bib-0029){ref-type="ref"}; Wu and de Champlain [1996](#phy213954-bib-0090){ref-type="ref"}), which subsequently increases PE‐induced force responses. However, during atherosclerosis which can increase oxidative stress, a phenotypic switch to a nonexcitable proproliferatory phenotype can occur; consequently, this leads to a reduction in abundance of IP~3~R1, and reduced IP~3~R‐dependent Ca^2+^ release with a dampened force response (Massaeli et al. [1999](#phy213954-bib-0049){ref-type="ref"}; Ewart et al. [2010](#phy213954-bib-0021){ref-type="ref"}). Moreover, IP~3~R1 knockout mice exhibit a blunted force response when stimulated with PE in the mesenteric artery (Santulli et al. [2017](#phy213954-bib-0070){ref-type="ref"}). The similar reduction in IP~3~R1 observed in this study could suggest that these rats have undergone a phenotypic switch resulting in a phenotype that is similar to an atherosclerotic state.

K^+^‐induced depolarizations activate the L‐type voltage‐operated Ca^2+^ channel (Ca~V~1.2) subsequently allowing entry of extracellular Ca^2+^ (Bolton [1979](#phy213954-bib-0011){ref-type="ref"}; Bülbring and Tomita [1987](#phy213954-bib-0015){ref-type="ref"}). Ca~V~1.2 regulates vascular resistance and thus, has a major role in regulating blood pressure (Gollasch and Nelson [1997](#phy213954-bib-0024){ref-type="ref"}; Sonkusare et al. [2006](#phy213954-bib-0076){ref-type="ref"}). The abundance of total Ca~V~1.2 was significantly reduced in both male growth restricted groups (Fig. [2](#phy213954-fig-0002){ref-type="fig"}A), which may help explain the decreased response to the K^+^‐induced depolarization (Table [1](#phy213954-tbl-0001){ref-type="table"}). Downregulation of Ca~V~1.2 through siRNA transfection (Kudryavtseva et al. [2014](#phy213954-bib-0044){ref-type="ref"}) or gene inactivation (Moosmang et al. [2003](#phy213954-bib-0054){ref-type="ref"}) is associated with a decrease in maximum response to K^+^‐induced depolarization. Ca~V~1.2 can exist as a full‐length channel (240 kDa) or be proteolytically cleaved at the C‐terminus producing a short‐truncated form (190 kDa) (De Jongh et al. [1991](#phy213954-bib-0019){ref-type="ref"}; Gomez‐Ospina et al. [2006](#phy213954-bib-0027){ref-type="ref"}; Schroder et al. [2009](#phy213954-bib-0073){ref-type="ref"}). The C‐terminus fragment is found to regulate the activity and expression of Ca~V~1.2 (Hulme et al. [2006](#phy213954-bib-0035){ref-type="ref"}; Bannister et al. [2013](#phy213954-bib-0006){ref-type="ref"}); therefore, the Ca~V~1.2 channel autoregulates its own expression. The C‐terminus fragment can translocate to the nucleus which increases promoter binding, reducing Ca~V~1.2 mRNA transcription and Ca~V~1.2 protein content (Schroder et al. [2009](#phy213954-bib-0073){ref-type="ref"}; Bannister et al. [2013](#phy213954-bib-0006){ref-type="ref"}). Our results show that total Ca~V~1.2 and the full‐length isoform is downregulated in both male growth restriction groups, whereas the abundance of the short‐truncated form is either unchanged (FR group) or increased (SR group) (see Table [3](#phy213954-tbl-0003){ref-type="table"}). These results suggest that Ca~V~1.2 is proteolytically cleaved forming the C‐terminus fragment which then inhibits the expression of Ca~V~1.2 (Schroder et al. [2009](#phy213954-bib-0073){ref-type="ref"}; Bannister et al. [2013](#phy213954-bib-0006){ref-type="ref"}) in these growth restricted male offspring. Furthermore, the C‐terminus fragment regulates the activity of Ca~V~1.2 as it reassociates at the plasma membrane and decreases the voltage sensitivity and current density of Ca~V~1.2 (Hulme et al. [2006](#phy213954-bib-0035){ref-type="ref"}; Bannister et al. [2013](#phy213954-bib-0006){ref-type="ref"}). Ca~V~1.2 can also influence gene transcription by stimulating Ca^2+^‐dependent transcriptional factors (Gollasch et al. [1998](#phy213954-bib-0025){ref-type="ref"}; Wamhoff et al. [2006](#phy213954-bib-0080){ref-type="ref"}; Kudryavtseva et al. [2014](#phy213954-bib-0044){ref-type="ref"}). Therefore, this excitation‐transcription coupling can affect the mesenteric arteries phenotypic expression, leading to both functional and structural changes.

Phenotypic switching following IUGR {#phy213954-sec-0016}
-----------------------------------

Studies have demonstrated that a loss of endothelial factors, coupled with a gain of proproliferatory factors due to oxidative stress, can cause a phenotypic switch leading to the development of vascular diseases, such as hypertension and atherosclerosis (Owens et al. [2004](#phy213954-bib-0064){ref-type="ref"}). Oxidative stress (Cambonie et al. [2007](#phy213954-bib-0016){ref-type="ref"}), hypertension (Ozaki et al. [2001](#phy213954-bib-0065){ref-type="ref"}; Alexander [2003](#phy213954-bib-0004){ref-type="ref"}; Brawley et al. [2003](#phy213954-bib-0013){ref-type="ref"}; Anderson et al. [2006](#phy213954-bib-0005){ref-type="ref"}; Tare et al. [2012](#phy213954-bib-0078){ref-type="ref"}) and endothelial dysfunction (Goodfellow et al. [1998](#phy213954-bib-0028){ref-type="ref"}; Leeson et al. [2001](#phy213954-bib-0047){ref-type="ref"}) are commonly reported to occur in arteries following IUGR, and therefore, presumably may affect these arteries phenotypic marker expression. A phenotypic switch can alter the VSMCs ability to proliferate and contract normally (Owens et al. [2004](#phy213954-bib-0064){ref-type="ref"}; Gomez and Owens [2012](#phy213954-bib-0026){ref-type="ref"}). Although phenotypic switching has been investigated in certain diseased states, this process has not been examined in VSMCs from offspring following IUGR. Specific protein marker expression (*α*‐actin, Myh11, TPM4) was examined between experimental groups, which are often used to characterize a phenotypic switch. The abundance of these specific protein markers was unchanged in both male and female FR compared to control diet groups, as well as between female SR and SC experimental groups. However, the abundance of Myh11 was significantly decreased in 6‐month‐old SR male offspring (Fig. [2](#phy213954-fig-0002){ref-type="fig"}F), while the abundance of *α*‐actin was increased compared to SC males (Fig. [2](#phy213954-fig-0002){ref-type="fig"}E). These findings would suggest that a switch from a normal contractile phenotype to a proproliferatory/migratory phenotype did not occur due to growth restriction in utero. However, it is imperative to take into consideration the abundance of Ca^2+^‐signaling proteins which regulate transcription factors, such as Ca~V~1.2 and IP~3~R1, which are often reportedly downregulated when the VSMC undergo a phenotypic switch (House et al. [2008](#phy213954-bib-0034){ref-type="ref"}) and can affect gene expression patterns. As stated previously, the abundance of Ca~V~1.2 and IP~3~R1 were significantly reduced in both male restricted groups (FR and SR; see Table [3](#phy213954-tbl-0003){ref-type="table"}), this may suggest the mesenteric artery has undergone a phenotypic switch to a more noncontractile state.

Six‐month‐old female mesenteric artery changes {#phy213954-sec-0017}
----------------------------------------------

This study discovered no differences in responsiveness to either a K^+^‐induced depolarization or PE‐stimulation (Table [1](#phy213954-tbl-0001){ref-type="table"}) in both female FR and SR experimental groups when compared to their respective control group (C and SC). Ca^2+^‐activated forces were likewise not different (Table [2](#phy213954-tbl-0002){ref-type="table"}), along with the abundance of most proteins investigated (Table [4](#phy213954-tbl-0004){ref-type="table"}); besides an increased abundance of Ca~V~1.2 in the FR females (Fig. [3](#phy213954-fig-0003){ref-type="fig"}A). Results from this study support previous findings of a gender‐specific effect associated with IUGR on vascular functionality (Ozaki et al. [2001](#phy213954-bib-0065){ref-type="ref"}; Mazzuca et al. [2010](#phy213954-bib-0050){ref-type="ref"}; Bourque et al. [2013](#phy213954-bib-0012){ref-type="ref"}). Females seem to be protected from the negative consequences of IUGR due to the protective mechanisms of the female placenta, which has a greater resistance to excessive glucocorticoid exposure during fetal development (Murphy et al. [2002](#phy213954-bib-0057){ref-type="ref"}; Clifton and Murphy [2004](#phy213954-bib-0018){ref-type="ref"}). However, some studies have shown a change in vascular responsiveness following IUGR in female offspring (Hemmings et al. [2005](#phy213954-bib-0032){ref-type="ref"}; Anderson et al. [2006](#phy213954-bib-0005){ref-type="ref"}; Bubb et al. [2007](#phy213954-bib-0014){ref-type="ref"}; Sathishkumar et al. [2015](#phy213954-bib-0071){ref-type="ref"}). Sathishkumar et al. ([2015](#phy213954-bib-0071){ref-type="ref"}) discovered an enhanced response to Angiotensin II (potent vasoconstrictor) in the mesenteric artery of 6‐month‐old females following a maternal protein restriction diet, however, these same arteries had no change in sensitivity to PE. Others have also shown an age‐specific difference (Hemmings et al. [2005](#phy213954-bib-0032){ref-type="ref"}; Anderson et al. [2006](#phy213954-bib-0005){ref-type="ref"}). A hypoxia‐induced growth restriction model significantly affected myogenic tone at 4‐months of age in females, whereas at 7‐months, no functional differences were found (Hemmings et al. [2005](#phy213954-bib-0032){ref-type="ref"}). Results may vary between the different studies due to the differences in specific age group investigated, or the severity and timing of the diverse growth restriction models employed. Innate sex‐specific differences in the regulation of several biological systems, such as the renin--angiotensin system (Woods et al. [2001](#phy213954-bib-0088){ref-type="ref"}, [2005](#phy213954-bib-0089){ref-type="ref"}), regulation of oxidative stress (Katkhuda et al. [2012](#phy213954-bib-0039){ref-type="ref"}; Ojeda et al. [2012](#phy213954-bib-0062){ref-type="ref"}) and blood pressure (Ojeda et al. [2007a](#phy213954-bib-0060){ref-type="ref"},[b](#phy213954-bib-0061){ref-type="ref"}), may contribute to the disparity in results between males and females in this study.

Conclusion {#phy213954-sec-0018}
==========

In conclusion, this is the first study to discover that the decrease in vascular responsiveness in IUGR males is caused by a reduced maximum Ca^2+^‐activated force response and likely contributed by the decreased abundance of important contractile proteins activated in the excitation‐contraction coupling pathways. Furthermore, the decrease in Ca^2+^‐signaling proteins and receptors/channels (Ca~V~1.2 and IP~3~R1) may contribute to the reduced contractility by possibly prompting a phenotypic switch to a more noncontractile phenotypic state. From this study, it was clear there was a sex‐specific disparity in the vascular changes associated with IUGR with restricted females showing no changes in contractile responsiveness to extracellular agonists, or direct Ca^2+^‐activated force, and generally no difference in the abundance of important contractile proteins.
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